Literature DB >> 20587693

The haploinsufficient Col3a1 mouse as a model for vascular Ehlers-Danlos syndrome.

T K Cooper1, Q Zhong, M Krawczyk, H-J Tae, G A Müller, R Schubert, L A Myers, H C Dietz, M I Talan, W Briest.   

Abstract

Vascular Ehlers-Danlos syndrome is a rare genetic disorder resulting from mutations in the α-1 chain of type III collagen (COL3A1) and manifesting as tissue fragility with spontaneous rupture of the bowel, gravid uterus, or large or medium arteries. The heterozygous Col3a1 knockout mouse was investigated as a model for this disease. The collagen content in the abdominal aorta of heterozygotes was reduced, and functional testing revealed diminishing wall strength of the aorta in these mice. Colons were grossly and histologically normal, but reduced strength and increased compliance of the wall were found in heterozygotes via pressure testing. Although mice demonstrated no life-threatening clinical signs or gross lesions of vascular subtype Ehlers-Danlos syndrome type IV, thorough histological examination of the aorta of heterozygous mice revealed the presence of a spectrum of lesions similar to those observed in human patients. Lesions increased in number and severity with age (0/5 [0%] in 2-month-old males vs 9/9 [100%] in 14-month-old males, P < .05) and were more common in male than female mice (23/26 [88.5%] vs 14/30 [46.7%] in 9- to 21-month-old animals, P < .05). Haploinsufficiency for Col3a1 in mice recapitulates features of vascular Ehlers-Danlos syndrome in humans and can be used as an experimental model.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20587693      PMCID: PMC2970629          DOI: 10.1177/0300985810374842

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  39 in total

1.  Ehlers-Danlos syndrome type IV.

Authors:  A P Barabas
Journal:  N Engl J Med       Date:  2000-08-03       Impact factor: 91.245

2.  Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type.

Authors:  M Pepin; U Schwarze; A Superti-Furga; P H Byers
Journal:  N Engl J Med       Date:  2000-03-09       Impact factor: 91.245

3.  A lamellar unit of aortic medial structure and function in mammals.

Authors:  H Wolinsky; S Glagov
Journal:  Circ Res       Date:  1967-01       Impact factor: 17.367

Review 4.  The NH(2)-terminal propeptides of fibrillar collagens: highly conserved domains with poorly understood functions.

Authors:  Paul Bornstein
Journal:  Matrix Biol       Date:  2002-04       Impact factor: 11.583

5.  Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV.

Authors:  U Schwarze; W I Schievink; E Petty; M R Jaff; D Babovic-Vuksanovic; K J Cherry; M Pepin; P H Byers
Journal:  Am J Hum Genet       Date:  2001-09-27       Impact factor: 11.025

Review 6.  Clinical and genetic features of vascular Ehlers-Danlos syndrome.

Authors:  Dominique P Germain
Journal:  Ann Vasc Surg       Date:  2002-05-21       Impact factor: 1.466

7.  Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome.

Authors:  Daniel P Judge; Nancy J Biery; Douglas R Keene; Jessica Geubtner; Loretha Myers; David L Huso; Lynn Y Sakai; Harry C Dietz
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

Review 8.  Causes and histopathology of ascending aortic disease in children and young adults.

Authors:  Deepali Jain; Harry C Dietz; Gretchen L Oswald; Joseph J Maleszewski; Marc K Halushka
Journal:  Cardiovasc Pathol       Date:  2011 Jan-Feb       Impact factor: 2.185

9.  Mice with a deletion in the first intron of the Col1a1 gene develop age-dependent aortic dissection and rupture.

Authors:  Otto Rahkonen; Ming Su; Harri Hakovirta; Ilpo Koskivirta; Sheriar G Hormuzdi; Eero Vuorio; Paul Bornstein; Risto Penttinen
Journal:  Circ Res       Date:  2003-11-20       Impact factor: 17.367

10.  FGF-2 stimulation affects calvarial osteoblast biology: quantitative analysis of nine genes important for cranial suture biology by real-time reverse transcription polymerase chain reaction.

Authors:  Jonathan A Mathy; Kelly Lenton; Randall P Nacamuli; Kenton D Fong; HanJoon M Song; Tony D Fang; George P Yang; Michael T Longaker
Journal:  Plast Reconstr Surg       Date:  2003-08       Impact factor: 4.730

View more
  20 in total

1.  Chronic treatment with a broad-spectrum metalloproteinase inhibitor, doxycycline, prevents the development of spontaneous aortic lesions in a mouse model of vascular Ehlers-Danlos syndrome.

Authors:  Hyun-Jin Tae; Shannon Marshall; Jing Zhang; Mingyi Wang; Wilfried Briest; Mark I Talan
Journal:  J Pharmacol Exp Ther       Date:  2012-07-19       Impact factor: 4.030

2.  Type III collagen modulates fracture callus bone formation and early remodeling.

Authors:  Emily L Miedel; Becky K Brisson; Todd Hamilton; Hadley Gleason; Gary P Swain; Luke Lopas; Derek Dopkin; Joseph E Perosky; Kenneth M Kozloff; Kurt D Hankenson; Susan W Volk
Journal:  J Orthop Res       Date:  2015-03-08       Impact factor: 3.494

3.  Doxycycline ameliorates the susceptibility to aortic lesions in a mouse model for the vascular type of Ehlers-Danlos syndrome.

Authors:  Wilfried Briest; Timothy K Cooper; Hyun-Jin Tae; Melissa Krawczyk; Nazli B McDonnell; Mark I Talan
Journal:  J Pharmacol Exp Ther       Date:  2011-03-01       Impact factor: 4.030

Review 4.  Type III collagen (COL3A1): Gene and protein structure, tissue distribution, and associated diseases.

Authors:  Helena Kuivaniemi; Gerard Tromp
Journal:  Gene       Date:  2019-05-07       Impact factor: 3.688

5.  Diminished type III collagen promotes myofibroblast differentiation and increases scar deposition in cutaneous wound healing.

Authors:  Susan W Volk; Yanjian Wang; Elizabeth A Mauldin; Kenneth W Liechty; Sherrill L Adams
Journal:  Cells Tissues Organs       Date:  2011-01-19       Impact factor: 2.481

6.  Targetable cellular signaling events mediate vascular pathology in vascular Ehlers-Danlos syndrome.

Authors:  Caitlin J Bowen; Juan Francisco Calderón Giadrosic; Zachary Burger; Graham Rykiel; Elaine C Davis; Mark R Helmers; Kelly Benke; Elena Gallo MacFarlane; Harry C Dietz
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

7.  Vascular Ehlers-Danlos syndrome: exploring the role of inflammation in arterial disease.

Authors:  Dianna M Milewicz; Amy J Reid; Alana C Cecchi
Journal:  Circ Cardiovasc Genet       Date:  2014-02

8.  Cholecystokinin receptor antagonist halts progression of pancreatic cancer precursor lesions and fibrosis in mice.

Authors:  Jill P Smith; Timothy K Cooper; Christopher O McGovern; Evan L Gilius; Qing Zhong; Jiangang Liao; Alfredo A Molinolo; J Silvio Gutkind; Gail L Matters
Journal:  Pancreas       Date:  2014-10       Impact factor: 3.327

9.  Type III collagen regulates osteoblastogenesis and the quantity of trabecular bone.

Authors:  Susan W Volk; Shalin R Shah; Arthur J Cohen; Yanjian Wang; Becky K Brisson; Laurie K Vogel; Kurt D Hankenson; Sherrill L Adams
Journal:  Calcif Tissue Int       Date:  2014-03-14       Impact factor: 4.333

10.  Vascular Ehlers-Danlos syndrome mutations in type III collagen differently stall the triple helical folding.

Authors:  Kazunori Mizuno; Sergei Boudko; Jürgen Engel; Hans Peter Bächinger
Journal:  J Biol Chem       Date:  2013-05-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.